Life Sciences and Healthcare
Developing solutions that will enable you to stay competitive in this rapidly evolving market with the support of our in-depth knowledge.
The Life Sciences and Healthcare sector is a dynamic and rapidly evolving market dedicated to improving quality of life and well-being.
The sector encompasses a range of activities from scientific research and technological innovation to the delivery of medical care and health services. It includes biotech, pharmaceuticals, medical device and healthcare services with each playing a crucial role in improving patient outcomes and addressing global health challenges.
In the wake of recent acceleration of this fast-changing environment, our team provides specialised services to help healthcare and life sciences organisations in a transformative fast-changing environment.
We assist many of our clients with mergers, acquisitions and becoming publicly listed, which has resulted in us being ranked as the number one auditor in the UK, for the number of AIM listed clients in Healthcare by the AIM Advisers Rankings Guide (January 2025).
Identifying your requirements
By understanding your needs, we work with you, applying our knowledge to shape strategies and understand financial implications allowing you maximise your organisation’s potential.
Identifying your requirements
Guidance all the way
Fostering long-term client relationships, we help you with practical management functions or outsourcing daily finance functions allowing you to focus on your organisation.
Guidance all the way
Navigating the hurdles
Understanding the everchanging regulatory environment, we support you on compliance responsibilities and increasingly complex financial reporting regulations.
Navigating the hurdles
Who we work with
We work with a range of Life Sciences and Healthcare organisations.
Life Sciences
Biotechnology
Drug discovery and Development
Pharmaceutical Services
Healthcare
Medical devices
Health and Social Care
Health Technology
Our latest deal
Crowe advised Roadside Real Estate Plc with their dual acquisition of Gardner Retail Limited and D.A. Roberts Fuels Limited.
Mergers and Acquisitions activity
Explore some of the completed transactions Crowe advised on.
The promotions of Ben Carter and Charlie Copp reinforce the firm’s strategic focus on high growth service lines and key sector specialisms.
From April 2026, changes to the UK capital allowances regime will affect how quickly businesses can claim tax relief on certain capital expenditure.
Crowe provided reporting accountant services to Halo Minerals PLC on its placing and admission to trading on AIM.
The promotions of Ben Carter and Charlie Copp reinforce the firm’s strategic focus on high growth service lines and key sector specialisms.
From April 2026, changes to the UK capital allowances regime will affect how quickly businesses can claim tax relief on certain capital expenditure.
Crowe provided reporting accountant services to Halo Minerals PLC on its placing and admission to trading on AIM.
Industry knowledge, pragmatic advice, tailored service
We care about your business. Close working relationships are at the heart of our service delivery which sees our clients stay with us year after year, trusting us for our specialist advice and open dialogue.
We understand the Life Sciences and Healthcare industry. Our expertise, market knowledge and access to professionals across our global network means we are well placed to offer insight and pragmatic advice to your businesses at each stage of its lifecycle.
We help you to make smart decisions that have lasting value. Working with you, we will help you to successfully adapt and overcome challenges in the life science and healthcare sector, both today and in the future.
Contact us
